((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

New funding from Biocurate will support a Monash University project that's developing a novel disease-modifying treatment for ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Crown Princess Mette-Marit of Norway is on sick leave due to medicinal side effects associated with her chronic lung disease, ...

Life challenges make this population very difficult to treat, but interventions that take their issues into account may ...

Researchers studied 20 patients who were assigned to 12 weeks of supplemental oxygen for 16 or more hours a day or no oxygen ...

Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to ...

Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension. Read why I ...

The Texas-based biotech sponsored a recent episode of “The Balancing Act,” a morning talk show that airs on Lifetime. Per an ...

Crown Princess Mette-Marit of Norway is on sick leave effective immediately due to side effects from a medication she is ...